<List><item><source>MED</source><extId>28133919</extId><pmcid>PMC5901404</pmcid><annotations><annotation><prefix>als.gov identifier: </prefix><exact>NCT00781859</exact><postfix> and NCT00798317), a</postfix><tags><tag><name>NCT00781859</name><uri>http://identifiers.org/clinicaltrials/NCT00781859</uri></tag></tags><id>http://europepmc.org/articles/PMC5901404#europepmc-b3d5cb99aab5f3e4899f56611693bbab</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>er: NCT00781859 and </prefix><exact>NCT00798317</exact><postfix>), an intravitreal i</postfix><tags><tag><name>NCT00798317</name><uri>http://identifiers.org/clinicaltrials/NCT00798317</uri></tag></tags><id>http://europepmc.org/articles/PMC5901404#europepmc-1b28c1c42c18cd52d123e2571db7b22c</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>als.gov identifier: </prefix><exact>NCT01429441</exact><postfix>) (Dugel PU etÂ al. </postfix><tags><tag><name>NCT01429441</name><uri>http://identifiers.org/clinicaltrials/NCT01429441</uri></tag></tags><id>http://europepmc.org/articles/PMC5901404#europepmc-0203e8f3f3925779e8377af9d55451b2</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>